Neurofilament light chain: An important step toward a disease biomarker in multiple sclerosis

Multiple sclerosis (MS) is a chronic progressive disorder of the CNS that leads to neurodegeneration and accumulation of neurologic disability. At disease onset, it is challenging to predict whether individual patients will have a benign or aggressive disease course, and whether individual patients will respond to disease-modifying therapies. MS phenotypes1 and diagnostic criteria2 are defined on the basis of clinical and MRI characteristics. They are limited in their ability to guide treatment decisions.

Source link

Related posts

clinical neurology; +118 new citations


Welcome to the Norman Fixel Institute for Neurological Diseases!


Near-infrared spectroscopy in vegetables and humans: An observational study.


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World